Genenta Other Current Assets vs Net Receivables Analysis

GNTA Stock

USD 5.13 0.17 3.21%

Genenta Science financial indicator trend analysis is much more than just examining Genenta Science SpA latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genenta Science SpA is a good investment. Please check the relationship between Genenta Science Other Current Assets and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Other Current Assets vs Net Receivables

Other Current Assets vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genenta Science SpA Other Current Assets account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Genenta Science's Other Current Assets and Net Receivables is 0.83. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Genenta Science SpA, assuming nothing else is changed. The correlation between historical values of Genenta Science's Other Current Assets and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Genenta Science SpA are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Current Assets i.e., Genenta Science's Other Current Assets and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Net Receivables

Most indicators from Genenta Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genenta Science SpA current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

The current year's Enterprise Value is expected to grow to about 128.7 M, whereas Selling General Administrative is forecasted to decline to about 3.3 M.

	2021	2022	2023	2024 (projected)
Interest Expense	11.7K	2.6M	3.0M	3.1M
Depreciation And Amortization	5.1K	6.0K	42.5K	44.6K

Interest Expense Depreciation And Amortization

Genenta Science fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock
Total Assets		-0.9	-0.8	1.0	0.74	-0.54	-0.48	-0.5	-0.08	0.48	0.78	0.81	-0.25	0.99	0.87	0.34	0.4	0.71	0.57	-0.8	-0.81	1.0	1.0	0.8	1.0	0.8
Other Current Liab	-0.9		0.87	-0.9	-0.93	0.84	0.16	0.79	0.07	-0.15	-0.94	-0.95	0.28	-0.84	-0.98	-0.49	-0.7	-0.91	-0.85	0.95	0.84	-0.9	-0.89	-0.94	-0.89	-0.94
Total Current Liabilities	-0.8	0.87		-0.82	-0.88	0.81	0.01	0.74	0.55	-0.01	-0.67	-0.67	0.69	-0.75	-0.78	-0.5	-0.63	-0.73	-0.78	0.87	0.99	-0.82	-0.8	-0.85	-0.82	-0.85
Total Stockholder Equity	1.0	-0.9	-0.82		0.75	-0.55	-0.48	-0.51	-0.1	0.47	0.78	0.8	-0.27	0.99	0.87	0.33	0.4	0.71	0.58	-0.81	-0.82	1.0	1.0	0.81	1.0	0.81
Other Liab	0.74	-0.93	-0.88	0.75		-0.91	0.17	-0.95	-0.22	-0.17	0.86	0.84	-0.46	0.66	0.86	0.58	0.89	0.82	0.93	-0.99	-0.83	0.75	0.73	0.96	0.74	0.96
Net Tangible Assets	-0.54	0.84	0.81	-0.55	-0.91		-0.3	0.93	0.25	0.31	-0.81	-0.78	0.4	-0.43	-0.82	-0.55	-0.84	-0.89	-0.95	0.86	0.77	-0.55	-0.52	-0.84	-0.54	-0.84
Net Debt	-0.48	0.16	0.01	-0.48	0.17	-0.3		-0.44	-0.34	-1.0	-0.14	-0.2	-0.39	-0.56	-0.25	0.51	0.55	-0.13	0.22	-0.06	0.06	-0.48	-0.5	-0.04	-0.49	-0.04
Retained Earnings	-0.5	0.79	0.74	-0.51	-0.95	0.93	-0.44		0.2	0.45	-0.77	-0.73	0.44	-0.39	-0.73	-0.62	-0.98	-0.75	-0.94	0.91	0.68	-0.51	-0.48	-0.87	-0.49	-0.87
Accounts Payable	-0.08	0.07	0.55	-0.1	-0.22	0.25	-0.34	0.2		0.34	0.23	0.24	0.95	-0.08	0.08	-0.34	-0.15	0.08	-0.13	0.17	0.58	-0.1	-0.09	-0.11	-0.12	-0.11
Cash	0.48	-0.15	-0.01	0.47	-0.17	0.31	-1.0	0.45	0.34		0.14	0.2	0.39	0.55	0.25	-0.52	-0.56	0.12	-0.22	0.06	-0.05	0.47	0.49	0.03	0.48	0.03
Non Current Assets Total	0.78	-0.94	-0.67	0.78	0.86	-0.81	-0.14	-0.77	0.23	0.14		1.0	0.02	0.7	0.97	0.4	0.7	0.94	0.84	-0.88	-0.62	0.78	0.76	0.88	0.76	0.88
Non Currrent Assets Other	0.81	-0.95	-0.67	0.8	0.84	-0.78	-0.2	-0.73	0.24	0.2	1.0		0.04	0.74	0.98	0.4	0.65	0.94	0.81	-0.86	-0.63	0.8	0.79	0.86	0.79	0.86
Other Assets	-0.25	0.28	0.69	-0.27	-0.46	0.4	-0.39	0.44	0.95	0.39	0.02	0.04		-0.23	-0.1	-0.47	-0.4	-0.06	-0.33	0.41	0.71	-0.27	-0.26	-0.35	-0.28	-0.35
Cash And Short Term Investments	0.99	-0.84	-0.75	0.99	0.66	-0.43	-0.56	-0.39	-0.08	0.55	0.7	0.74	-0.23		0.81	0.3	0.29	0.62	0.46	-0.72	-0.77	0.99	0.99	0.71	0.99	0.71
Net Receivables	0.87	-0.98	-0.78	0.87	0.86	-0.82	-0.25	-0.73	0.08	0.25	0.97	0.98	-0.1	0.81		0.38	0.62	0.96	0.83	-0.89	-0.76	0.87	0.86	0.9	0.86	0.9
Common Stock Shares Outstanding	0.34	-0.49	-0.5	0.33	0.58	-0.55	0.51	-0.62	-0.34	-0.52	0.4	0.4	-0.47	0.3	0.38		0.69	0.3	0.38	-0.52	-0.51	0.33	0.33	0.35	0.32	0.35
Non Current Liabilities Total	0.4	-0.7	-0.63	0.4	0.89	-0.84	0.55	-0.98	-0.15	-0.56	0.7	0.65	-0.4	0.29	0.62	0.69		0.63	0.86	-0.84	-0.56	0.4	0.38	0.78	0.39	0.78
Inventory	0.71	-0.91	-0.73	0.71	0.82	-0.89	-0.13	-0.75	0.08	0.12	0.94	0.94	-0.06	0.62	0.96	0.3	0.63		0.89	-0.83	-0.69	0.71	0.69	0.86	0.7	0.86
Other Current Assets	0.57	-0.85	-0.78	0.58	0.93	-0.95	0.22	-0.94	-0.13	-0.22	0.84	0.81	-0.33	0.46	0.83	0.38	0.86	0.89		-0.91	-0.71	0.58	0.55	0.93	0.57	0.93
Other Stockholder Equity	-0.8	0.95	0.87	-0.81	-0.99	0.86	-0.06	0.91	0.17	0.06	-0.88	-0.86	0.41	-0.72	-0.89	-0.52	-0.84	-0.83	-0.91		0.83	-0.81	-0.79	-0.98	-0.8	-0.98
Total Liab	-0.81	0.84	0.99	-0.82	-0.83	0.77	0.06	0.68	0.58	-0.05	-0.62	-0.63	0.71	-0.77	-0.76	-0.51	-0.56	-0.69	-0.71	0.83		-0.82	-0.8	-0.8	-0.82	-0.8
Net Invested Capital	1.0	-0.9	-0.82	1.0	0.75	-0.55	-0.48	-0.51	-0.1	0.47	0.78	0.8	-0.27	0.99	0.87	0.33	0.4	0.71	0.58	-0.81	-0.82		1.0	0.81	1.0	0.81
Total Current Assets	1.0	-0.89	-0.8	1.0	0.73	-0.52	-0.5	-0.48	-0.09	0.49	0.76	0.79	-0.26	0.99	0.86	0.33	0.38	0.69	0.55	-0.79	-0.8	1.0		0.78	1.0	0.78
Capital Stock	0.8	-0.94	-0.85	0.81	0.96	-0.84	-0.04	-0.87	-0.11	0.03	0.88	0.86	-0.35	0.71	0.9	0.35	0.78	0.86	0.93	-0.98	-0.8	0.81	0.78		0.8	1.0
Net Working Capital	1.0	-0.89	-0.82	1.0	0.74	-0.54	-0.49	-0.49	-0.12	0.48	0.76	0.79	-0.28	0.99	0.86	0.32	0.39	0.7	0.57	-0.8	-0.82	1.0	1.0	0.8		0.8
Common Stock	0.8	-0.94	-0.85	0.81	0.96	-0.84	-0.04	-0.87	-0.11	0.03	0.88	0.86	-0.35	0.71	0.9	0.35	0.78	0.86	0.93	-0.98	-0.8	0.81	0.78	1.0	0.8

Click cells to compare fundamentals

Genenta Science Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Genenta Science SpA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genenta Science's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genenta Science Spa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genenta Science Spa Stock:

How To Invest In Genenta

Details

Is Genenta Stock a good investment?

Details

What is Genenta Science's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. If investors know Genenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genenta Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.52)

Return On Assets

(0.26)

Return On Equity

(0.43)

The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genenta Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genenta Other Current Assets vs Net Receivables Analysis

Other Current Assets vs Net Receivables

Other Current Assets vs Net Receivables Correlation Analysis

Correlation Coefficient

Other Current Assets

Net Receivables

Genenta Science fundamental ratios Correlations

Genenta Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Other Liab
Common Stock	- 0.98	Other Stockholder Equity
Capital Stock	- 0.98	Other Stockholder Equity
Non Current Liabilities Total	- 0.98	Retained Earnings
Net Receivables	- 0.98	Other Current Liab